Vaccines, DNA
DBCAT005633Pharmacologic class
Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to... A DrugBank category of 1 drug. 1 of them is approved.
What you can answer from here — as of January 13, 2022
Which targets do Vaccines, DNA share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account